Based on the present study findings, the Interleukin 6, is one of the powerful predictors of coronaryartery disease in patients with type 2 diabetes mellitus, since these values are significantly increased in later stages of T2DM and CADwhen compared to newly diagnosed CAD patients. Here, IL6 is linked to diabetes mellitus.